Sitra

SET Ventures, established in 2007 and based in Amsterdam, Netherlands, is a venture capital firm focusing on early to growth-stage investments in Europe. The company specializes in digital technology for a carbon-free energy system, backing pioneering startups with sustainable solutions and a strong digital DNA. Its investment priority lies in sectors such as distributed infrastructure, energy retail, buildings, mobility, industry, and enabling technologies. SET Ventures typically invests between €0.5 million to €6 million per portfolio company, aiming to take a seat on the supervisory board.

Headai Ltd. is a Finnish company founded in 2015 that specializes in developing software robots designed to automate intellectual tasks across various business operations. The company offers teachable robots as a cloud service, enabling organizations to streamline repetitive processes and enhance efficiency. Headai's technology combines natural language processing, reinforcement learning, and insights from cognitive sciences to create interactive and reliable bots that can learn quickly and adapt to user needs. Additionally, Headai provides tools for discovering relevant content and accessing information tailored to individual interests, thereby supporting corporate learning and decision-making. By leveraging its proprietary algorithms, Headai helps clients uncover valuable insights from large datasets, facilitating a better understanding of complex information.

Naava specializes in the development of living green wall technology aimed at enhancing indoor air quality and promoting well-being. By incorporating bioactive plants into their innovative designs, Naava creates healthy environments that combine the functions of air purifiers, humidifiers, and active green walls. This technology effectively reduces harmful chemicals and revitalizes indoor air, allowing businesses and individuals to experience the natural air-purifying benefits of nature within urban settings. Naava's mission is to reconnect people with nature, enabling them to breathe cleaner air and feel healthier in the spaces where they live, work, and learn. The company envisions a future where millions can access the refreshing qualities of Nordic forest air indoors.

Optomeditech Oy, established in June 2011, specializes in the development and marketing of medical devices, specifically intravenous catheters and blood collection needles. The company focuses on enhancing patient and caregiver safety through innovative technology. Its products utilize transillumination of skin tissue to facilitate cannulation, thereby improving the success rate of first-time procedures for healthcare professionals. Currently, Optomeditech is in the process of obtaining CE mark and FDA 510(k) approvals for its inaugural IV catheter product, with plans to enter the market in the first half of 2015.

NaturVention Enclosed Ecosystem Technologies solves global problems by combining nature and technology. We are a fast growing, venture-backed technology company. We challenge ourselves to find solutions to global problems by looking into nature, from where we have been able to find solutions for thousands of years already. We have developed patented solutions by enhancing nature’s own processes. We use the brightest technology to enhance those processes in order to create products that are easy to use and which help people to feel better by providing clean and healthy air and food.

Omegawave is a company that develops training and performance management solutions for athletes, teams, and coaches. Their products allow users to quickly and non-invasively assess how an athlete's body responds to exertion, providing insights to optimize training sessions and avoid injuries or overtraining. Omegawave's technology measures cardiac, metabolic, and central nervous system activity, offering real-time data and physiological information to coaches. The company's solutions are used by various elite sports organizations, including multiple Olympic Federations, premier soccer teams, and franchises from the NFL, MLS, NHL, and MLB. Omegawave was recognized in 2014 by the UK-based Sports Technology Awards for developing the 'Best Performance Technology for Elite Athletes.'

VisionPlus is a Finnish venture capital firm established in 2011, located in Helsinki. The firm focuses on investing in digital products, including applications, games, and services across various digital platforms. Its investment portfolio encompasses software-as-a-service, mobile applications, and internet services, as well as special content intellectual property deals. The management team at VisionPlus possesses extensive experience in technology, entrepreneurship, and seed investments, having successfully developed and managed large-scale business and development organizations in a global context.

Savo-Solar Oy, a Mikkeli, Finland-based manufacturer of solar thermal solutions.

Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, the company has developed the SmartFocus technology, which utilizes navigated transcranial magnetic stimulation (TMS) with 3D navigation for precise targeting of brain areas. Nexstim's product offerings include the NBT system, designed for treating major depressive disorder and chronic neuropathic pain, and the NBS system, used for pre-surgical mapping of the speech and motor cortices. The NBS systems are primarily sold to universities and teaching hospitals. Nexstim operates in various markets, including Finland, Europe, and North America, with a significant portion of its revenue generated in North America. The company's commitment lies in addressing significant unmet clinical needs and improving the quality of life for patients.

Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, the company has developed the SmartFocus technology, which utilizes navigated transcranial magnetic stimulation (TMS) with 3D navigation for precise targeting of brain areas. Nexstim's product offerings include the NBT system, designed for treating major depressive disorder and chronic neuropathic pain, and the NBS system, used for pre-surgical mapping of the speech and motor cortices. The NBS systems are primarily sold to universities and teaching hospitals. Nexstim operates in various markets, including Finland, Europe, and North America, with a significant portion of its revenue generated in North America. The company's commitment lies in addressing significant unmet clinical needs and improving the quality of life for patients.

FIT Biotech is a medical biotechnology company focused on the development and commercialization of its proprietary Gene Transport Unit (GTU) technology. The company specializes in applications related to DNA vaccination and immuno- and gene therapies. Its innovative approach includes the development of antibody therapies for cancer immunotherapy and DNA vaccines aimed at preventing infectious diseases, such as human immunodeficiency virus. FIT Biotech's technology enables the production of antibodies within the human body, offering a more integrated solution compared to traditional industrial methods. Through its advancements, the company aims to enhance treatment options in the biopharma sector.

Vivoxid Ltd. develops, manufactures, and markets biomaterial products for the medical device sector. The company offers MetAlive soft tissue attachment technology for implant surfaces. BonAlive bioactive glass and biodegradable polymer composite products in bone reconstruction and FiberLive biodegradable fiberglass composites for load-bearing biodegradable implants. It has distributors in northern Europe, the United Kingdom, southern Europe, Italy, Greece, Turkey, the Middle East, and Saudi Arabia. The company was founded in 2001 and is based in Turku, Finland.

Ipsat Therapies, a biotechnology company, develops intestinal protection systems in antibiotic treatment. It focuses on the development of products for the prevention of antibiotic resistance, antibiotic-associated diarrhea, and hospital associated infections. The company offers bioengineered enzyme, which removes the excess unabsorbed harmful antibiotic in intestine and maintains a normal intestinal microflora. It also develops various antibiotics, including penicillin, cephalosporin, carbapenems, and fixed combination products. Ipsat Therapies Oy was founded in 1999 and is based in Helsinki, Finland.

The company develops and delivers technology for converting ocean waves to electricity. AW-Energy has developed WaveRoller - a fully submerged wave energy converter which utilizes wave surge phenomenon. This commonplace effect is observed in near-shore waters where the circular motion of water particles present in open sea waves changes into elliptical circulation due to more shallow bottom. Before the waves break, typically at the depth of 8-20 metres this elliptical motion is so flat that it is essentially a horizontal back-and-forth movement of water. WaveRoller device is a Panel anchored at its base on the sea bed. The back and forth movement of the wave surge moves the Panel, transferring the kinetic energy to piston pumps. The pumps create a great deal of pressure which is fed into a combination of hydraulic motor/generator, which in turn produces electricity. The nominal capacity of a single commercial-scale Panel ranges between 500 – 1000 kW, depending on the wave resources available on the site. WaveRoller has the ability to generate energy on a wide spectrum of wave states and is also well suited for locations where wave periods are long and the swell is strong. A series of WaveRoller devices can be combined into an array, thus resulting in a wave farm. Since the plant construction is modular with a high degree of independence between individual units, there is no natural upper limit to the number of WaveRoller units that can be used, therefore offering a high level of scalability and reliability. The electricity output from an individual Panel is connected to a hub/substation, thus making it easy to plug-in new units in separate project development stages, as the new capacity is added to the farm. Also, any potential underperformance or service & maintenance breaks of individual units have no impact on the remaining units, thus ensuring uninterrupted power output from the overall farm. The first prototypes were designed and patent applications were filed as early as in 1999, when Rauno Koivusaari, the original inventor co-operated with Fortum Research Centre during the conceptual phase. Since then the technology has evolved following numerous laboratory and wave-tank test trials and ongoing mathematical simulations. Open sea trails started in 2004 and included the Gulf of Finland, marine tests conducted in the European Marine Energy Centre (EMEC), Scotland, and an own testing site in Peniche, Portugal. The subsequent successes and encouraging test results led to continuous increase in the scale of the demonstration plant. The latest demonstration plant/farm consisting of three 100kW WaveRoller units (total nominal capacity of the farm 300kW) is to be deployed in Peniche, Portugal, during the second quarter of 2012. The final assembly is nearing completion in the first quarter of 2012 and will be awaiting suitable weather conditions for the deployment in the following months. The farm will be connected to national grid in Portugal. The company has already secured all the necessary permits and, additionally, holds a licence for 1MW grid connection.